Found 10 matching trials
Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy
PHASE4he goal of this clinical trial is to compare the mitochondrial redox effect...
Location
Mansoura university hospitals
Safety, Tolerability and PK of Imeglimin in Japanese Volunteers
PHASE1This study will assess the pharmacokinetics of single and repeated doses of...
Location
Hammersmith Medicines Research (HMR)
Bioequivalence Study to Compare Imeglimin HCl 500 mg Film Coated Tablets Versus Twymeeg Tablets 500 mg
PHASE1An Open Label, Balanced, Randomized, Single dose, Two treatment, Two sequen...
Location
Veeda Clinical Research Ltd.
Effect of Cimetidine on the PK of Imeglimin
PHASE1The trial is an open-label assessment of the interaction of imeglimin with ...
Location
Hammersmith Medicines Research (HMR)
A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes
PHASE2This study will assess the efficacy and safety/tolerability of 4 doses of I...
Location
Pauls Stradins Clinical University Hospital
Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects
PHASE1This is a Phase 1, single-centre, open-label, parallel-group study in subje...
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
PHASE4Study subjects will be randomly assigned to the three groups and receive th...
Status
Active Not Recruiting
Location
Center Hospital of the National Center for Global Health and Medicine
Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations
PHASE1An open label, randomized, single-dose, two-sequence, two-period, crossover...
Location
Advanced Research Center (ARC)
Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects
PHASE1The purpose of this study is to assess the effect of a single therapeutic d...
Location
Hammersmith Medicines Research (HMR)
Bioequivalence of Imeglimin Tablet Formulations
PHASE1This is an open-label assessment of the bioequivalence of two 500 mg-tablet...
Location
Hammersmith Medicines Research (HMR)